September 2014

New Product - Nimenrix

Nimenrix (Neisseria meningitidis polysaccharide conjugate vaccine) is indicated for active immunisation of individuals from the age of 12 months through 55 years against invasive meningococcal diseases caused by Neisseria meningitidis serogroups A, C, W-135 and Y. Nimenrix is available as a powder for reconstitution + 0.5 mL solvent in single glass vials.

This list is a summary of only some of the changes that have occurred over the last month. Before prescribing, always refer to the full product information.

Copyright © MIMS Australia Pty Ltd. All rights reserved.

MIMS Australia
Level 2, 1 Chandos Street
St Leonards NSW 2065
Phone: 1800 800 629
info@mims.com.au
www.mims.com.au